Related Experiment Video
Updated: Dec 10, 2025

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
Long non-coding RNA XIST binding to let-7c-5p contributes to rheumatoid arthritis through its effects on
Zong-Qiang Wang1, Dian-Hui Xiu2, Jin-Lan Jiang3,4
1Medical Department, China-Japan Union Hospital of Jilin University, Changchun, China.
Background:
Rheumatoid arthritis (RA), a chronic autoimmune disease, affects around 1% population worldwide, with the life quality of patients severely reduced. In this study, it is intended to explore the role of long non-coding RNA X-inactive specific transcript (lncRNA XIST) in RA and the underlying mechanisms associated with let-7c-5p and signal transducer and activator of transcription 3 (STAT3).
Methods:
LncRNA XIST, let-7c-5p, and STAT3 expressions were determined in RA and normal cartilage tissues, and their relationship was analyzed in osteoblasts. The regulatory effects of lncRNA XIST in RA were investigated when XIST expression was upregulated or downregulated in osteoblasts. TNF-α, IL-2, IL-6, alkaline phosphatase (ALP), osteocalcin, TGF-β1, and IGF1 were measured in vivo in RA rats.
Results:
LncRNA XIST and STAT3 were expressed at high levels and let-7c-5p expressed at a low level in RA cartilage tissues. LncRNA XIST silencing or let-7c-5p enhancement led to decreased levels of TNF-α, IL-2, and IL-6, suggestive of suppressed inflammatory response, and increased levels of ALP, osteocalcin, TGF-β1, and IGF-1 as well as reduced damage in cartilage tissues.
Conclusion:
LncRNA XIST downregulation could promote proliferation and differentiation of osteoblasts in RA, serving as a future therapeutic target for RA.
Insights
Downregulating long non-coding RNA XIST (lncRNA XIST) in rheumatoid arthritis (RA) promotes osteoblast function and reduces inflammation. This suggests lncRNA XIST is a potential therapeutic target for RA treatment.
Area of Science:
- Molecular Biology
- Immunology
- Rheumatology
Background:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease impacting 1% of the global population, significantly reducing patient quality of life.
- This study investigates the role of long non-coding RNA XIST (lncRNA XIST) in RA pathogenesis.
- The research explores the underlying mechanisms involving let-7c-5p and signal transducer and activator of transcription 3 (STAT3).
Purpose of the Study:
- To explore the role of lncRNA XIST in rheumatoid arthritis (RA).
- To elucidate the mechanisms of lncRNA XIST involving let-7c-5p and STAT3 in RA.
- To evaluate lncRNA XIST as a potential therapeutic target for RA.
Main Methods:
- Assessed lncRNA XIST, let-7c-5p, and STAT3 expression in RA and normal cartilage tissues.
- Analyzed the relationship between these molecules in osteoblasts.
- Investigated the regulatory effects of XIST modulation (upregulation/downregulation) in osteoblasts.
- Measured inflammatory markers (TNF-α, IL-2, IL-6) and bone markers (ALP, osteocalcin, TGF-β1, IGF1) in vivo in RA rat models.
Main Results:
- High expression of lncRNA XIST and STAT3, and low expression of let-7c-5p were observed in RA cartilage.
- Silencing lncRNA XIST or enhancing let-7c-5p reduced inflammatory markers (TNF-α, IL-2, IL-6).
- These modulations increased bone formation markers (ALP, osteocalcin, TGF-β1, IGF-1) and decreased cartilage damage.
Conclusions:
- Downregulation of lncRNA XIST promotes osteoblast proliferation and differentiation in RA.
- lncRNA XIST serves as a potential therapeutic target for rheumatoid arthritis.
- The interplay between lncRNA XIST, let-7c-5p, and STAT3 is crucial in RA progression.
Related Concept Videos
Inheritance of Chromatin Structures
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
The JAK-STAT Signaling Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
MicroRNAs

